Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
33 public companies · 33 exchange-listed
33
Total Companies
33
Exchange Listed
29
Filed 10-K
9
States Represented
Total Sector Revenue
$39.40B
Aggregate of 26 companies with XBRL data
Avg Net Margin
-14.7%
Intensely competitive· Based on 26 filings
Sector Analysis · Sprytne.com
As of March 2026, the Medical Laboratories sector (SIC 8071) reports a combined revenue of $39.40B across 26 SEC-tracked entities. With an average net margin of -14.7%, this industry is classified as loss-making on average. LABCORP HOLDINGS INC. leads the sector with $13.95B in reported revenue. The data is derived exclusively from official SEC EDGAR XBRL submissions and reflects the most recently filed 10-K annual reports.
Data aggregated from SEC EDGAR XBRL submissions · Updated March 2026
| Rank | Company | Revenue | Net Income | Net Margin | vs Industry Avg |
|---|---|---|---|---|---|
| #1 | LABCORP HOLDINGS INC.LH | $13.95B | $876.5M | 6.3% | +21.0pp |
| #2 | QUEST DIAGNOSTICS INCDGX | $11.04B | $992.0M | 9.0% | +23.7pp |
| #3 | EXACT SCIENCES CORPEXAS | $3.25B | $-207,949,000 | -6.4% | +8.3pp |
| #4 | Fortrea Holdings Inc.FTRE | $2.72B | $-986,200,000 | -36.2% | -21.5pp |
| #5 | Natera, Inc.NTRA | $2.31B | $-208,160,000 | -9.0% | +5.7pp |
| Industry Average | $1.52B | $-26,345,290.077 | -14.7% | baseline | |
Aclarion, Inc.
CIK: 0001635077 · DE · 10-K: 2026-03-18
Advanced Biomed Inc.
CIK: 0001941029 · NV · 10-K: 2025-10-08
AMERICAN SHARED HOSPITAL SERVICES
CIK: 0000744825 · CA · 10-K: 2025-04-04
BillionToOne, Inc.
CIK: 0002070849 · DE · 10-K: 2026-03-11
BIODESIX INC
CIK: 0001439725 · DE · 10-K: 2026-02-26
BioNexus Gene Lab Corp
CIK: 0001737523 · WY · 10-K: 2025-04-15
Burning Rock Biotech Ltd
CIK: 0001792267 ·
CapForce Inc.
CIK: 0001293818 · DE · 10-K: 2025-08-21
CareDx, Inc.
CIK: 0001217234 · DE · 10-K: 2026-02-25
Caris Life Sciences, Inc.
CIK: 0002019410 · TX · 10-K: 2026-03-03
CASTLE BIOSCIENCES INC
CIK: 0001447362 · DE · 10-K: 2026-02-26
Celcuity Inc.
CIK: 0001603454 · DE · 10-K: 2025-03-31
EXACT SCIENCES CORP
CIK: 0001124140 · · 10-K: 2026-02-13
EXAGEN INC.
CIK: 0001274737 · DE · 10-K: 2026-03-10
First Choice Healthcare Solutions, Inc.
CIK: 0001416876 · DE · 10-K: 2026-03-11
Fortrea Holdings Inc.
CIK: 0001965040 · · 10-K: 2026-02-26
Fulgent Genetics, Inc.
CIK: 0001674930 · DE · 10-K: 2026-02-27
GRAIL, Inc.
CIK: 0001699031 · DE · 10-K: 2026-03-12
Guardant Health, Inc.
CIK: 0001576280 · DE · 10-K: 2026-02-19
LABCORP HOLDINGS INC.
CIK: 0000920148 · · 10-K: 2026-02-24
LUDWIG ENTERPRISES, INC.
CIK: 0001960262 · NV · 10-K: 2026-03-16
Lumexa Imaging Holdings, Inc.
CIK: 0002071288 · DE
MDxHealth SA
CIK: 0001872529 · C9
Natera, Inc.
CIK: 0001604821 · DE · 10-K: 2026-02-27
Perceptive Capital Solutions Corp
CIK: 0002017526 · E9 · 10-K: 2026-03-12
Personalis, Inc.
CIK: 0001527753 · DE · 10-K: 2026-02-26
PSYCHEMEDICS CORP
CIK: 0000806517 · DE · 10-K: 2025-03-24
QUEST DIAGNOSTICS INC
CIK: 0001022079 · DE · 10-K: 2026-02-26
RadNet, Inc.
CIK: 0000790526 · DE · 10-K: 2026-03-02
Renalytix plc
CIK: 0001811115 · X0 · 10-K: 2024-09-30
SERA PROGNOSTICS, INC.
CIK: 0001534969 · DE · 10-K: 2026-03-18
VERACYTE, INC.
CIK: 0001384101 · DE · 10-K: 2026-02-26
YD Bio Ltd
CIK: 0002011674 · E9